The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Chlamydia trachomatis: impact on human reproduction
Abstract
Chlamydia trachomatis infections are the most prevalent bacterial sexually transmitted infections (STI) recognized throughout the world. Worldwide, the magnitude of morbidity associated with sexually transmitted chlamydial infections is enormous. C.trachomatis is a common cause of urethritis and cervicitis, and sequelae include pelvic inflammatory disease (PID), ectopic pregnancy, tubal factor infertility, epididymitis, proctitis and reactive arthritis. The sharp worldwide increase in the incidence of PID during the past two decades has led to the secondary epidemics of tubal factor infertility and ectopic pregnancy. Chlamydial PID is the most important preventable cause of infertility and adverse pregnancy outcome. Chlamydial infections, like STI in general, are primarily a woman's health care issue since the manifestations and consequences are more damaging to the reproductive health in women than in men. Based on the available evidence, approximately 20% of women with chlamydial lower genital tract infection will develop PID, approximately 4% develop chronic pelvic pain, 3% infertility, and 2% adverse pregnancy outcome. However, these estimates are based on relatively weak evidence. Research on the link between C.trachomatis and male aspects of infertility has been much more limited. Currently recommended treatment regimens include azithromycin in a single dose or doxycycline for 7 days. These therapies are highly efficacious. Timely management of sex partners is essential for decreasing the risk for re-infection. Immunopathogenesis of C.trachomatis infection is one of the main focal points of current research into Chlamydia. Chlamydial infection fills the general prerequisites for disease prevention by screening, i.e. chlamydial infections are highly prevalent, usually asymptomatic, are associated with significant morbidity, can be reliably diagnosed, and are treatable. Screening programmes for C.trachomatis will be of paramount importance in the prevention of long-term sequelae. The cost of screening is only a fraction of the health care costs incurred due to complications resulting from undiagnosed and untreated chlamydial infections. Current strategies to control C.trachomatis still largely depend on clinic-based screening of symptomatic patients, and have not been successful. The development of highly sensitive and specific nucleic acid amplification tests for the diagnosis of chlamydial infections has been an important advance in the ability to conduct population-based screening programmes to prevent complications. Thus, the case for screening is clearly made, but much detail remains to be worked out.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome Sequence of an Obligate Intracellular Pathogen of Humans: Chlamydia trachomatis
Stephens, R. S., Kalman, S., Lammel, C., Fan, J., Marathe, R., Aravind, L., Mitchell, W., Olinger, L., Tatusov, R. L., Zhao, Q., et al. (1998) · Science · doi:10.1126/science.282.5389.754 · Cited by 1,563
Weström, L. (1980) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(80)91077-7 · Cited by 730
Factors that affect outcome of in-vitro fertilisation treatment
Templeton, A., Morris, J. K., & Parslow, W. (1996) · The Lancet · doi:10.1016/s0140-6736(96)05291-9 · Cited by 708
1998 Guidelines for Treatment of Sexually Transmitted Diseases: (547782006-001)
(1997) · PsycEXTRA Dataset · doi:10.1037/e547782006-001 · Cited by 621
Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis
Beatty, W. L., Morrison, R., & Byrne, G. I. (1994) · Microbiological Reviews · doi:10.1128/mmbr.58.4.686-699.1994 · Cited by 588
Genital chlamydial infections: Epidemiology and reproductive sequelae
Cates, W., & Wasserheit, J. N. (1991) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(91)90559-a · Cited by 544
Gravett, M. G. (1986) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1986.03380140069024 · Cited by 544
Current methods of laboratory diagnosis of Chlamydia trachomatis infections
Black, C. M. (1997) · Clinical Microbiology Reviews · doi:10.1128/cmr.10.1.160 · Cited by 503
Causes of the Acute Urethral Syndrome in Women
Stamm, W. E., Wagner, K. F., Amsel, R., Alexander, E. R., Turck, M., Counts, G. W., & Holmes, K. K. (1980) · New England Journal of Medicine · doi:10.1056/nejm198008213030801 · Cited by 481
Chlamydial Infections: (First of Three Parts)
Schachter, J. (1978) · New England Journal of Medicine · doi:10.1056/nejm197802232980805 · Cited by 467
Cited by
Price, M. J., Ades, A., Soldan, K., Welton, N. J., Macleod, J., Simms, I., DeAngelis, D., Turner, K. M., & Horner, P. J. (2016) · Health Technology Assessment · doi:10.3310/hta20220 · Cited by 494
Sexually transmitted diseases and infertility
Tsevat, D. G., Wiesenfeld, H. C., Parks, C., & Peipert, J. F. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.08.008 · Cited by 449
Peipert, J. F. (2003) · New England Journal of Medicine · doi:10.1056/nejmcp030542 · Cited by 383
Genital tract infections and infertility
Pellati, D., Mylonakis, I., Bertoloni, G., Fiore, C., Andrisani, A., Ambrosini, G., & Armanini, D. (2008) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2008.03.009 · Cited by 347
Pathogenesis of Genital Tract Disease Due to Chlamydia trachomatis
Darville, T., & Hiltke, T. J. (2010) · The Journal of Infectious Diseases · doi:10.1086/652397 · Cited by 334
Repeat Infection With Chlamydia and Gonorrhea Among Females: A Systematic Review of the Literature
Hosenfeld, C. B., Workowski, K. A., Berman, S., Zaidi, A., Dyson, J., Mosure, D., Bolan, G., & Bauer, H. M. (2009) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181a2a933 · Cited by 326
Van Der Pol, B., Ferrero, D. V., Buck-Barrington, L., Hook, E., Lenderman, C., Quinn, T., Gaydos, C. A., Lovchik, J., Schachter, J., Moncada, J., et al. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.3.1008-1016.2001 · Cited by 286
Genital Chlamydia trachomatis infections
Bébéar, C., & de Barbeyrac, B. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.02647.x · Cited by 283
Gallegos, G., Ramos, B., Santiso, R., Goyanes, V., Gosálvez, J., & Fernández, J. L. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.06.035 · Cited by 252
Adachi, K., Nielsen-Saines, K., & Klausner, J. D. (2016) · BioMed Research International · doi:10.1155/2016/9315757 · Cited by 118
Metadata
- Authors
- Paavonen, J.
- Venue
- Human Reproduction Update
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-09-01
- Volume
- 5
- Issue
- 5
- Pages
- 433-447
- ISSN
- 1355-4786 (ISSN-L)
- 1460-2369
- OpenAlex
- W2107239395
- Cited by
- 475
- References
- 59
- FWCI
- 8.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.